Cnbc
@cnbc·4.2M subscribers·16.1K videos
Why Novo Nordisk’s Weight Loss Pill Has Taken Off
Posted
April 7, 2026
Views
72,657
Likes
538
Comments
167
Engagement
0.97%
April 7, 2026
72,657
538
167
0.97%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Novo Nordisk's weight loss pill is expanding the obesity treatment market as an alternative to injectable GLP-1 medications. CNBC spoke with patients about their experience on the pill and explains how the drug is facing competition from Eli Lilly's oral weight loss pill. Watch the video to learn more.
Produced, Shot, and Edited by: Ryan Baker
Reporter: Annika Kim Constantino
Animation by: Emily Park
Managing Producer: Beatriz Bajuelos
Senior Managing Producer: Tala Hadavi
Additional Footage: Novo Nordisk, Eli Lilly, Getty Images
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Want to get ahead at work with AI? Sign up for CNBC's new online course, Beyond the BasicsHow to Use AI to Supercharge Your Work. Learn advanced AI skills like building custom GPTs and using AI agents to boost your productivity today. Sign up today
Connect with CNBC News Online
Get the latest news
Follow CNBC on LinkedIn
Follow CNBC News on Instagram
Follow CNBC News on Facebook
Follow CNBC on Threads
Follow CNBC News on X
Follow CNBC on WhatsApp
#CNBC
Why Novo Nordisk’s Weight Loss Pill Has Taken Off
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
